About: Xavier Delavenne

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Xavier Delavenne Goto Sponge NotDistinct Permalink

An Entity of Type : foaf:Person, within Data Space : data.idref.fr associated with source document(s)

Attributes	Values
type	Person
sameAs	Delavenne, Xavier (1977-....) Delavenne, Xavier (1977-....) Delavenne, Xavier (1977-....)
Life Event	http://www.idref.fr/127597611/birth
preferred label	Delavenne, Xavier (1977-....)
name	Xavier Delavenne
dbpedia-owl:citizenship	http://sws.geonames.org/3017382/
Language	http://lexvo.org/id/iso639-3/fra
isni:identifierValid	0000000358364475
Given name	Xavier
familyName	Delavenne
has biographical i...tion (Deprecated)	Directeur d'une thèse d'exercice de Médecine soutenue à l'Université Claude Bernard (Lyon 1) en 2017 Enseignant-chercheur à l'université de St Etienne UFR Médecine (Loire, France). Praticien hospitalier au CHRU de St Etienne. Responsable du service Pharmacologie, toxicologie et gaz du sang. Il est rattaché au laboratoire de recherche Sainbiose, Santé ingénierie biologie St Etienne (Université INSERM), équipe DVH, dysfonctions vasculaires et de l'hémostase. Il dirige régulièrement des thèses ou est membre de jurys de thèses Auteur d'une thèse de doctorat de recherche clinique Innovation technologique Santé publique spécialisée en Pharmacologie Clinique à l'université de St Etienne en 2011 Titulaire d'un Mémoire de DES‎ en Pharmacie industrielle et biomédicale (thèse d'exercice en pharmacie) à l'université de Lyon 1 en 2007
gender	male
ORCID iD	0000-0001-7134-0713
is sameAs of	Delavenne, Xavier (1977-....) Delavenne, Xavier (1977-....) Delavenne, Xavier (1977-....)
is Thesis advisor of	http://www.sudoc.fr/20147798X/id http://www.sudoc.fr/182052516/id Effet de l'administration de charbon active sur l'absorption complexe du rivaroxaban http://www.sudoc.fr/201733366/id http://www.sudoc.fr/270451501/id http://www.sudoc.fr/237023369/id http://www.sudoc.fr/242764665/id http://www.sudoc.fr/268309841/id Développement et validation d' une méthode de dosage du rituximab par LC-MS/MS, application au STP en oncologie http://www.sudoc.fr/271988703/id http://www.sudoc.fr/271802324/id
is Author of	http://www.sudoc.fr/127617116/id http://www.sudoc.fr/160543460/id Pharmacokinetics of fondaparinux 1.5 mg once daily in a real-world cohort of patients with renal impairment undergoing major orthopaedic surgery Risk of Direct Oral Anticoagulant Bioaccumulation in Patients with Pulmonary Hypertension Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulants A Pharmacokinetic-Pharmacodynamic Model for Predicting the Impact of CYP2C9 and VKORC1 Polymorphisms on Fluindione and Acenocoumarol During Induction Therapy http://hub.abes.fr/edp/periodical/therapie/2014/volume_70/issue_3/therapie140006/w Value of quantifying ABC transporters by mass spectrometry and impact on in vitro-to-in vivo prediction of transporter-mediated drug-drug interactions of rivaroxaban Rivaroxaban pharmacodynamics in healthy volunteers evaluated with thrombin generation and the active protein C system modeling and assessing inter-individual variability http://hub.abes.fr/edp/periodical/therapie/2012/volume_67/issue_2/th122058/w Effect of Activated Charcoal on Rivaroxaban Complex Absorption. Impact of age on in vitro metabolism of clopidogrel: a potential explanation for high on-treatment platelet reactivity in the elderly? Clustering Absorption Profiles of Rivaroxaban Using Between Subject Model Mixture Investigation of PK-PD drug-drug interaction between acenocoumarol and amoxicillin plus clavulanic acid. Antipsychotics: A Real or Confounding Risk Factor for Venous Thromboembolism? A SAEM Algorithm for Fused Lasso Penalized NonLinear Mixed Effect Models: Application to Group Comparison in Pharmacokinetics https://archive-ouverte.unige.ch/unige:26333#id Pharmacokinetics for haemophilia treaters: Meaning of PK parameters, interpretation pitfalls, and use in the clinic Direct oral anticoagulants are associated with limited damage of endothelial cells of the blood-brain barrier mediated by the thrombin/PAR-1 pathway
is primary topic of	http://www.idref.fr/127597611
is Opponent of	http://www.sudoc.fr/224031503/id http://www.sudoc.fr/279288840/id http://www.sudoc.fr/256088403/id
is Thesis referee of	http://www.sudoc.fr/261058592/id http://www.sudoc.fr/234110015/id

Faceted Search & Find service v1.13.91 as of Aug 16 2018

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software